Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sagent Pharm Inc (SGNT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 715,130
  • Shares Outstanding, K 33,090
  • Annual Sales, $ 318,300 K
  • Annual Income, $ -21,880 K
  • 36-Month Beta 1.65
  • Price/Sales 2.25
  • Price/Cash Flow 0.00
  • Price/Book 2.83
  • Price/Earnings ttm 53.00
  • Earnings Per Share ttm 0.41
  • Most Recent Earnings 0.02 on 05/03/16
  • Next Earnings Date 08/16/16
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.64 +0.55%
on 08/01/16
21.88 -0.55%
on 08/10/16
+0.07 (+0.32%)
since 07/29/16
3-Month
12.40 +75.48%
on 05/31/16
21.88 -0.55%
on 08/10/16
+9.41 (+76.19%)
since 05/27/16
52-Week
10.55 +106.26%
on 05/03/16
21.88 -0.55%
on 08/10/16
+1.72 (+8.58%)
since 08/28/15

Most Recent Stories

More News
Aeterna Zentaris Forms Strategic Review Committee and Appoints Michael Ward as CEO

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the "Company"), announced today that it has formed a special committee of independent directors (the "Strategic Review Committee")...

AEZS.TO : 3.48 (+18.37%)
AEZS : 2.80 (+19.66%)
SGNT : 21.76 (+0.14%)
Athenex Inc. announces the promotion of Jeffrey M. Yordon to the position of Chief Operating Officer

Athenex, Inc. announced today the promotion of Jeffrey M. Yordon to the position of Chief Operating Officer (COO) for the company effective upon Board approval. Previously Mr. Yordon was the President...

NHKFF : 14.4000 (unch)
SGNT : 21.76 (+0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Sagent Pharmaceuticals, Inc. is a pharmaceutical company that develops and sources products with primary focus on generic injectable pharmaceuticals. Products offered by the Company cover a range of anti-infective, oncolytic and critical care indications in a variety of presentations, including single-...

See More

Support & Resistance

2nd Resistance Point 21.77
1st Resistance Point 21.77
Last Price 21.76
1st Support Level 21.75
2nd Support Level 21.73

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.